CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, Ravindra, Chao, Mark P., Alizadeh, Ash A., Pang, Wendy W., Jaiswal, Siddhartha, Gibbs, Kenneth D., van Rooijen, Nico, Weissman, Irving L.·2009·Cell

DOI 10.1016/j.cell.2009.05.045

Cited by (1,001)

Items 301–400 of 1,001

Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2 -V617F
Pontus Lundberg, Hitoshi Takizawa, Lucia Kubovčáková, Guoji Guo, Hui Hao-Shen, Stephan Dirnhofer, Stuart H. Orkin, Markus Gabriel Manz, Radek C. Skoda · 2014 · The Journal of Experimental Medicine
MYC: Master Regulator of Immune Privilege
Stephanie C. Casey, Virginie Baylot, Dean W. Felsher · 2017 · Trends in Immunology
Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
Haoran Sun, Shun Li Wang, Shican Yan, Yu Zhang, Peter Jon Nelson, Hu‐Liang Jia, Lun–Xiu Qin, Qiongzhu Dong · 2019 · Frontiers in Oncology
Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles
Manjing Li, Zhaojian Xu, Lu Zhang, Mingyue Cui, Manhui Zhu, Yang Guo, Rong Sun, Junfei Han, E Song, Yao He et al. · 2021 · ACS Nano
Myeloid Cell Origins, Differentiation, and Clinical Implications
Kipp Weiskopf, Peter John Schnorr, Wendy W. Pang, Mark Ping Chao, Akanksha Chhabra, Jun Seita, Mingye Feng, Irving L. Weissman · 2016 · Microbiology Spectrum
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
Ran Liu, Huiting Wei, Peng Gao, Hu Yu, Ke Wang, Zheng Fu, Baohui Ju, Meng Zhao, Shangwen Dong, Zhijun Li et al. · 2017 · Oncotarget
The role of cancer stem cells in the modulation of anti-tumor immune responses
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, Soldano Ferrone · 2018 · Seminars in Cancer Biology
Independent prognostic variables in acute myeloid leukaemia
Matthew L. Smith, Robert Kerrin Hills, David J. Grimwade · 2010 · Blood Reviews
Harnessing the antitumor potential of macrophages for cancer immunotherapy
Kristen B. Long, Gregory Lawrence Beatty · 2013 · OncoImmunology
Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
Suchismita Mohanty, Ketan Yerneni, Johanna Lena Theruvath, Claus Moritz Graef, Hossein Nejadnik, Olga D. Lenkov, Laura Jean Pisani, Jarrett Rosenberg, Siddhartha S. Mitra, Alejandro Sweet-Cordero et al. · 2019 · Cell Death and Disease
The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity
Yasuyuki Saito, Satomi Komori, Takenori Kotani, Yoji Murata, Takashi Matozaki · 2022 · Cancers
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
Zhida Liu, Chuanhui Han, Yang‐Xin Fu · 2019 · Cellular and Molecular Immunology
Mononuclear phagocyte heterogeneity in cancer: Different subsets and activation states reaching out at the tumor site
Damya Laoui, Eva Van Overmeire, Kiavash Movahedi, Jan Van den Bossche, Elio Schouppe, Camille Mommer, Alexandros Nikolaou, Yannick Morias, Patrick DE BAETSELIER, Jo A. Van Ginderachter · 2011 · Immunobiology
Attenuation of microRNA-126 Expression That Drives CD34+38− Stem/Progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication
David C. de Leeuw, Fedor Denkers, Marjolein C. Olthof, Arjo P. Rutten, Walter Pouwels, Gerrit Jan Schuurhuis, Gert Jan Ossenkoppele, Linda Smit · 2014 · Cancer Research
PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
Guang‐Tao Yu, Lin‐Lin Bu, Cong‐Fa Huang, Wen‐Feng Zhang, Wan-Jun Chen, Jorge Silvio Gutkind, Ashok B. Kulkarni, Zhi‐Jun Sun · 2015 · Oncotarget
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia
Norbert Vey, Jacques Delaunay, Giovanni Martinelli, Walter Fiedler, Emmanuel Raffoux, Thomas Prébet, Carlos Gomez‐Roca, Cristina Papayannidis, Maxim Kebenko, Peter Paschka et al. · 2016 · Oncotarget
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed, Fang‐Ming Chen, Jiayi Ye, Yang Shi, Twan Lammers, Bruno G. De Geest, Zhi Ping Xu, Haijun Yu · 2021 · Advanced Materials
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Mohammadi, Elham Faryadi, Maryam Haddadi, Amirhossein Merati, Farbod Ghobadinezhad, Roshanak Amirian, Zhila Izadi, Jamshid Hadjati · 2024 · Cell Death and Disease
CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
SUZUKI, SHIGEMASA, YOKOBORI, TAKEHIKO, TANAKA, NARITAKA, SAKAI, MAKOTO, SANO, AKIHIKO, INOSE, TAKANORI, SOHDA, MAKOTO, NAKAJIMA, MASANOBU, MIYAZAKI, TATSUYA, KATO, HIROYUKI et al. · 2012 · Oncology Reports
Regulation of efferocytosis as a novel cancer therapy
Zhou, Yunxiang, Yao, Yihan, Deng, Yongchuan, Shao, Anwen · 2020 · Cell Communication and Signaling
Original insights on thrombospondin-1-related antireceptor strategies in cancer
Albin Jeanne, Christophe Schneider, Laurent Martiny, Stéphane Dedieu · 2015 · Frontiers in Pharmacology
Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ
Jens H. W. Pahl, Kitty M.C. Kwappenberg, Eleni Maria Varypataki, Susy Justo Santos, Marieke L. Kuijjer, Susan Mohamed, Juul Wijnen, Maarten J. D. van Tol, Anne‐Marie Cleton-Jansen, Rudolph Maarten Egeler et al. · 2014 · Journal of Experimental & Clinical Cancer Research
Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies
Komal Qureshi-Baig, Pit Ullmann, Serge Haan, Elisabeth Letellier · 2017 · Molecular Cancer
Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy
Yu-Ting Huang, Yuchi Ma, Peng Gao, Zhi Yao · 2017 · Journal of Thoracic Disease
Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects
Xiao Qi Yang, Wenli Feng, Rong Wang, Feifei Yang, Lina Wang, Shayan Chen, Yongxin Ru, Tao Cheng, Guoguang Zheng · 2017 · OncoImmunology
Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
Pottayil G. Sasikumar, Murali Ramachandra · 2018 · BioDrugs
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones
Bauke de Boer, Janine C. M. Prick, Maurien G. M. Pruis, Peter Keane, Maria Rosaria Imperato, Jennifer Jaques, Annet Z. Brouwers-Vos, Shanna M. Hogeling, Carolien M. Woolthuis, Marije T. Nijk et al. · 2018 · Cancer Cell
Targeting CD47 in Sézary syndrome with SIRPαFc
Lisa D. S. Johnson, Swati Banerjee, Oleg Kruglov, Natasja Nielsen Viller, Steven Michael Horwitz, Alexander M. Lesokhin, Jasmine M. Zain, Christiane Querfeld, Robert Chen, Craig Y. Okada et al. · 2019 · Blood Advances
Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments
Yushu Joy Xie, Michael Lawrence Dougan, Jessica R. Ingram, Novalia Pishesha, Tao Fang, Noor Momin, Hidde L. Ploegh · 2020 · Cancer Immunology Research
Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery
Hui Liu, Kangdong Liu, Zigang Dong · 2020 · Cancer Research
Smart hydrogel: A new platform for cancer therapy
Guo Li, Zi-Ming Fu, Haoran Li, Ruibo Wei, Jing Guo, Haiwang Wang, Jian Qi · 2025 · Advances in Colloid and Interface Science
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging
Binje Vick, Maja Rothenberg, Nadine Sandhöfer, Michela Carlet, Cornelia Finkenzeller, Christina Krupka, M Grunert, Andreas Trumpp, Selim Corbacioglu, Martin Ebinger et al. · 2015 · PLoS ONE
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Xingcheng Yang, Ling Ma, Xiaoying Zhang, Liang Huang, Jia Wei · 2022 · Experimental Hematology and Oncology
Metabolism and polarization regulation of macrophages in the tumor microenvironment
Jia Wang, Shichao Mi, Muyao Ding, Xue Li, Shengtao Yuan · 2022 · Cancer Letters
Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy
Karen Delavigne, E. Bérard, Sarah Bertoli, Jill Corre, Éliane Duchayne, Cécile Demur, Véronique Mansat‐De Mas, Cécile Borel, Muriel Picard, Muriel Alvarez et al. · 2013 · Haematologica
Macrophages: Gatekeepers of Tissue Integrity
Yonit Lavin, Miriam Mérad · 2013 · Cancer Immunology Research
Cancer stem cells as a therapeutic target in bladder cancer
Nazi Aghaalikhani, Nadereh Rashtchizadeh, Pejman Shadpour, Abdolamir Allameh, Marzieh Mahmoodi · 2018 · Journal of Cellular Physiology
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy
Diane Evrard, Petr Szturz, Annemilaï Tijeras‐Raballand, Lucile Astorgues‐Xerri, Chloé Abitbol, Valérie Paradis, Éric Raymond, Sébastien Albert, B. Barry, Sandrine J. Faivre · 2018 · Oral Oncology
Monoclonal anti‐CD47 interference in red cell and platelet testing
Randall W. Velliquette, Judith Aeschlimann, Julie Kirkegaard, Gayane Shakarian, C. Lomas, Connie M. Westhoff · 2018 · Transfusion
Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets
Luise Müller, Antje Tunger, Ioana Plesca, Rebekka Wehner, Achim Temme, Dana Westphal, Friedegund Elke Meier, Michael Philipp Bachmann, Marc Schmitz · 2020 · Frontiers in Immunology
Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer
Aasa Shimizu, Kenjiro Sawada, Masaki Kobayashi, Misa Yamamoto, Taro Yagi, Yasuto Kinose, Michiko Kodama, Kae Hashimoto, Tadashi Kimura · 2021 · Molecular Cancer Research
Signal‐regulatory protein α from the NOD mouse binds human CD 47 with an exceptionally high affinity – implications for engraftment of human cells
Lai Shan Kwong, Marion H. Brown, A. Neil Barclay, Deborah Hatherley · 2014 · Immunology
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu, Lin Zhang, Lin Yang, Hui Li, Runmei Li, Jinpu Yu, Lili Yang, Feng Wei, Cihui Yan, Qian Sun et al. · 2017 · Frontiers in Immunology
Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
Hongcheng Yang, Ruoyang Shao, Hongxin Huang, Xinlong Wang, Zhili Rong, Ying Lin · 2019 · Cancer Medicine
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
Runzhe Shu, Vera J. Evtimov, Maree V. Hammett, Nhu-Y. N. Nguyen, Junli Zhuang, Peter J. Hudson, Maureen Howard, Aleta Pupovac, Alan O. Trounson, Richard L. Boyd · 2021 · Molecular Therapy — Oncolytics
Cellular and molecular biology of small cell lung cancer: an overview.
Niki Karachaliou, Sara Pilotto, Chiara Lazzari, Emilio Bria, Filippo de Marinis, Rafael Rosell · 2016 · Europe PMC (PubMed Central)
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
Axel Schulenburg, Katharina Blatt, Sabine Cerny‐Reiterer, Irina Sadovnik, Harald Herrmann, Brigitte Marian, Thomas W. Grunt, Christoph Carl Zielinski, Peter Valent · 2015 · Journal of Hematology & Oncology
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Mingxue Fan, Minghao Li, Lipeng Gao, Sicong Geng, Jing Wang, Yiting Wang, Zhiqiang Yan, Lei Yu · 2017 · Journal of Hematology & Oncology
Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
Pulak Ranjan Nath, Dipasmita Pal-Nath, Ajeet Mandal, Margaret C. Cam, Anthony L. Schwartz, David D. Roberts · 2019 · Cancer Immunology Research
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
Robyn J. Puro, Myriam N. Bouchlaka, Ronald R. Hiebsch, Benjamin J. Capoccia, Michael J. Donio, Pamela Toy Manning, William A. Frazier, Robert W. Karr, Daniel S. Pereira · 2019 · Molecular Cancer Therapeutics
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
Xu Cao, Bolei Li, Jing Chen, Jessica Dang, Siqi Chen, Emine Gulsen Gunes, Bo Xu, Lei Tian, Sabina Muend, Mustafa Raoof et al. · 2021 · Journal for ImmunoTherapy of Cancer
The immune landscape of common CNS malignancies: implications for immunotherapy
Martina Ott, Robert Michael Prins, Amy B. Heimberger · 2021 · Nature Reviews Clinical Oncology
Fcγ receptors and immunomodulatory antibodies in cancer
Felipe Gálvez‐Cancino, Alexander P. Simpson, Cristóbal Costoya, Ignacio Garcia Matos, Danwen Qian, Karl S. Peggs, Kevin Litchfield, Sergio A. Quezada · 2023 · Nature reviews. Cancer
Chemotherapy targeting cancer stem cells.
Haiguang Liu, Lin Li Lv, Kai Yang · 2015 · PubMed Central
Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses
Boning Liu, Huaizu Guo, Jin Xu, Ting Gao Qin, Qingcheng Guo, Nana Gu, Dapeng Zhang, Weizhu Qian, Jianxin Dai, Sheng Hou et al. · 2017 · mAbs
Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
Jing Chen, Dan-Xue Zheng, Xing-Juan Yu, Hong-Wei Sun, Yi-Tuo Xu, Yaojun Zhang, Jing Xu · 2019 · OncoImmunology
Leukemia stem cells.
S. Lane, D. Gilliland · 2010 · Seminars in Cancer Biology
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
Vita Golubovskaya, Robert Berahovich, Hua Zhou, Shirley Xu, Hizkia Harto, Le Li, Cheng‐Chi Chao, Mike Ming Mao, Lijun Wu · 2017 · Cancers
A Proteomics and Transcriptomics Approach to Identify Leukemic Stem Cell (LSC) Markers
Francesco Bonardi, Fabrizia Fusetti, Patrick Deelen, Djoke van Gosliga, Edo Vellenga, Jan Jacob Schuringa · 2012 · Molecular & Cellular Proteomics
Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment
Sushil Kumar, David C. Calianese, Raymond B. Birge · 2017 · Immunological Reviews
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
Bernhard M. Kiss, Nynke S. van den Berg, Robert D. Ertsey, Kelly Marie McKenna, Kathleen E. Mach, Chiyuan Amy Zhang, Jens-Peter Volkmer, Irving L. Weissman, Eben Lloyd Rosenthal, Joseph C. Liao · 2019 · Clinical Cancer Research
Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy
Chen, Siqi, Lai, Seigmund W. T., Brown, Christine E., Feng, Mingye · 2021 · Frontiers in Immunology
Just eat it: A review of CD47 and SIRP-α antagonism
Bryan T. Oronsky, Corey Allan Carter, Tony R. Reid, Franck Brinkhaus, Susan Jane Knox · 2020 · Seminars in Oncology
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
Claudia Galassi, Martina Musella, Nicoletta Manduca, Ester Maccafeo, Antonella Sistigu · 2021 · Cells
Understanding of leukemic stem cells and their clinical implications
Xuefei Wang, Shile Huang, Ji‐Long Chen · 2017 · Molecular Cancer
Cell Membrane‐Camouflaged NIR II Fluorescent Ag2Te Quantum Dots‐Based Nanobioprobes for Enhanced In Vivo Homotypic Tumor Imaging
Jingjing Zhang, Yi Lin, Hui Zhou, He He, Jiaojiao Ma, Mengyao Luo, Zhiling Zhang, Dai‐Wen Pang · 2019 · Advanced Healthcare Materials
Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed
Tailong Qu, Baiyong Li, Yifei Wang · 2022 · Biomarker Research
Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done
Jiang‐Jie Duan, Wen Qiu, Senlin Xu, Bin Wang, Xian-Zong Ye, Yi‐Fang Ping, Xia Zhang, Xiu‐Wu Bian, Shi‐Cang Yu · 2013 · Stem Cells and Development
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
Daniel G. Guy, Geoffrey L. Uy · 2018 · Current Hematologic Malignancy Reports
The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions
Juan C. Osorio, Patrick T Smith, David A. Knorr, Jeffrey V. Ravetch · 2023 · Cancer Cell
“Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis
Chia Chi M. Ho, Nan Guo Ring, Jonathan T. Sockolosky, Aaron M. Ring, Kipp Weiskopf, Engin Özkan, Yasuo Mori, Irving L. Weissman, K. Christopher García · 2015 · Journal of Biological Chemistry
Childhood acute myeloid leukaemia
Jeffrey E. Rubnitz, Hiroto Inaba · 2012 · British Journal of Haematology
Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Dalil Hannani, Antonella Sistigu, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer, Laurence Zitvogel · 2011 · The Cancer Journal
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera, Brigitte M. Pützer · 2018 · Seminars in Cancer Biology
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
Jennifer Sun, Barbara Muz, Kinan Alhallak, Matea Markovic, Shannon Gurley, Zhe Wang, Nicole Guenthner, Katherine Wasden, Mark Aaron Fiala, Justin A. King et al. · 2020 · Cancers
CD47: the next checkpoint target for cancer immunotherapy
Ridong Feng, Zhao Hai, Jianguo Xu, Chongyang Shen · 2020 · Critical Reviews in Oncology/Hematology
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
Irène Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein, Markus Wallwiener, Martina Scharpff, Massimo Saini, Tim Holland‐Letz, Hans‐Peter Sinn et al. · 2014 · Oncotarget
Universal monitoring of minimal residual disease in acute myeloid leukemia
Elaine Coustan‐Smith, Guangchun Song, Sheila A. Shurtleff, Allen Eng Juh Yeoh, Wee Joo Chng, Siew Peng Chen, Jeffrey E. Rubnitz, Ching‐Hon Pui, James R. Downing, Dario Campana · 2018 · JCI Insight
Cancer stem cells in bladder cancer: a revisited and evolving concept
Keith Syson Chan, Jens-Peter Volkmer, Irving L. Weissman · 2010 · Current Opinion in Urology
The CD47 “don't eat me signal” is highly expressed in human ovarian cancer
Rachel M. Brightwell, Kassondra S. Grzankowski, Shashi Lele, Kevin Hasegawa Eng, Maariya Arshad, H. Chen, Kunle O. Odunsi · 2016 · Gynecologic Oncology
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
Louise W. Treffers, Toine ten Broeke, Thies Rösner, J.H. Marco Jansen, Michel van Houdt, Steffen Kahle, Karin Schornagel, Paul Verkuijlen, Jan M. Prins, Katka Franke et al. · 2019 · Cancer Immunology Research
Targeting tumor-associated macrophages in head and neck squamous cell carcinoma
Bolei Li, Min Ren, Xuedong Zhou, Qi Han, Lei Cheng · 2020 · Oral Oncology
A siRNA-Assisted Assembly Strategy to Simultaneously Suppress “Self” and Upregulate “Eat-Me” Signals for Nanoenabled Chemo-Immunotherapy
Yuxi Zhang, Zhenghai Zhang, Senlin Li, Liang Zhao, Dongdong Li, Ziyang Cao, Xiaoding Xu, Xianzhu Yang · 2021 · ACS Nano
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, Jiayi Li, Heng Cao, Hengyi Xu, Lin Cong, Dongxu Ma, Xiang Wang, Jiaqi Liu · 2025 · Journal of Hematology & Oncology
Engineering humanized mice for improved hematopoietic reconstitution
Adam C.B. Drake, Qingfeng Chen, Jianzhu Chen · 2012 · Cellular and Molecular Immunology
CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer
Shenglan Gu, Ting Ni, Jing Wang, Yao Liu, Qiong Fan, Yiwei Wang, Ting Huang, Yiwei Chu, Xiao Sun, Yudong Wang · 2018 · Journal of Immunology Research
Programmed cell clearance: Molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation
Bengt Fadeel, Ding Xue, Valerian E. Kagan · 2010 · Biochemical and Biophysical Research Communications
Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
Kulthida Vaeteewoottacharn, Ryusho Kariya, Phattarin Pothipan, Sawako Fujikawa, Chawalit Pairojkul, Sakda Waraasawapati, K. Kuwahara, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada · 2018 · Translational Oncology
Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
Javad Masoumi, Abdollah Jafarzadeh, Jalal Abdolalizadeh, Haroon Zaman Khan, Philippe Jeandet, Hamed Mirzaei, Hamid Reza Mirzaei · 2020 · Acta Pharmaceutica Sinica B
Role of autophagy on cancer immune escape
Yalan Duan, Xiaoqing Tian, Qian Liu, Jianhua Jin, Juanjuan Shi, Yongzhong Hou · 2021 · Cell Communication and Signaling
Deciphering the role of CD47 in cancer immunotherapy
Yue Liu, Linjun Weng, Yanjin Wang, Jin Zhang, Qi Wu, Pengcheng Zhao, Yufeng Shi, Ping Wang, Lan Fang · 2023 · Journal of Advanced Research
Lifting the innate immune barriers to antitumor immunity
Carla Vanina Rothlin, Sourav Ghosh · 2020 · Journal for ImmunoTherapy of Cancer
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 + T cells
Hongmei Chen, Xiuxiu Cong, Chenxi Wu, Xuan Wu, Jialiang Wang, Kuirong Mao, Jie Li, Ge Zhu, Feiqi Liu, Xiandi Meng et al. · 2020 · Science Advances
Integrating the “Immunome” in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial Design
Susann Winter, Saeed Shoaie, Shahram Y. Kordasti, Uwe Platzbecker · 2020 · Journal of Clinical Oncology
Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways
Saeid Taghiloo, Hossein Asgarian‐Omran · 2020 · Critical Reviews in Oncology/Hematology
CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration
Mingsu Shi, Yun Gu, Kaifeng Jin, Hanji Fang, Yifan Chen, Yifan Cao, Xin Liu, Kunpeng Lv, Xudong He, Chao Lin et al. · 2021 · Cancer Immunology Immunotherapy
Immunotherapy prospects for acute myeloid leukaemia
A. John Barrett, Katarina Le Blanc · 2010 · Clinical & Experimental Immunology
Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
Lian, Shu, Xie, Ruizhi, Ye, Yuying, Lu, Yusheng, Cheng, Yunlong, Xie, Xiaodong, Li, Shuhui, Jia, Lee · 2019 · Scientific Reports
Desirable cell death during anticancer chemotherapy
Clara Locher, Rosa Conforti, Laetitia Aymeric, Yuting Ma, Takahiro Yamazaki, Sylvie Rusakiewicz, Antoine Tesnière, François Ghiringhelli, Lionel Apétoh, Yannis Morel et al. · 2010 · Annals of the New York Academy of Sciences
Assessment of minimal residual disease in acute myeloid leukemia
David J. Grimwade, Paresh Vyas, Sylvie D. Freeman · 2010 · Current Opinion in Oncology